Ourania Walraven
Adult Health · New York, NYNPI 1992825632
Payments from drug & device makers
Across 266 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Abbott$797
- Merck$722
- AstraZeneca$694
- Boehringer Ingelheim$526
- Alnylam Pharmaceuticals Inc.$416
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 69 | $1,029 |
| Abbott | 16 | $797 |
| Merck | 30 | $722 |
| AstraZeneca | 37 | $694 |
| Boehringer Ingelheim | 29 | $526 |
| Alnylam Pharmaceuticals Inc. | 15 | $416 |
| Kiniksa Pharmaceuticals International, PLC | 8 | $277 |
| Daiichi Sankyo Inc. | 9 | $210 |
| Impulse Dynamics (USA) Inc. | 5 | $185 |
| Scpharmaceuticals Inc. | 7 | $175 |
| Bridgebio Pharma, Inc. | 6 | $154 |
| Amgen | 6 | $112 |
| Cvrx, Inc. | 2 | $110 |
| E.r. Squibb & Sons, L.L.C. | 5 | $104 |
| Kestra Medical Technology Services, Inc. | 2 | $88 |
| Lexicon Pharmaceuticals, Inc. | 4 | $76 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $63 |
| Lilly USA, LLC | 2 | $48 |
| Bayer | 2 | $42 |
| One Lambda, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| United Therapeutics Corporation | 1 | $21 |
| Veloxis Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Pfizer | 1 | $12 |
| Biobeat USA Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,971 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 28 | $829,455 |
| EntrestoSacubitril/Valsartan | 63 | $79,772 |
| JardianceEmpagliflozin | 43 | $61,517 |
| EliquisApixaban | 47 | $40,475 |
| FarxigaDapagliflozin Propanediol | 25 | $30,614 |
| Repatha SureclickEvolocumab | 31 | $28,197 |
| LokelmaSodium Zirconium Cyclosilicate | 20 | $20,634 |
| Eplerenone | 23 | $1,969 |
| Metoprolol Succinate | 59 | $649 |
| Atorvastatin Calcium | 35 | $477 |
| Carvedilol | 30 | $282 |
| Spironolactone | 18 | $236 |
| Tamsulosin Hcl | 11 | $148 |
| Rosuvastatin Calcium | 15 | $140 |
| Losartan Potassium | 13 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $12 | $869,93075 claims |
| NovartisEntresto | $1,029 | $79,77263 claims |
| Boehringer IngelheimJardiance | $526 | $61,51743 claims |
| AstraZenecaFarxiga, Lokelma | $694 | $51,24945 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.